BRIEF-Gelteq Begins Preclinical Trial for Novel Gel-Based Antihistamine Targeting Allergy Market

Reuters
Sep 05
BRIEF-<a href="https://laohu8.com/S/GELS">Gelteq</a> Begins Preclinical Trial for Novel Gel-Based Antihistamine Targeting Allergy Market

Sept 5 (Reuters) - Gelteq Ltd GELS.O:

  • GELTEQ ANNOUNCES COMMENCEMENT OF PRECLINICAL TRIAL FOR NOVEL GEL-BASED ANTIHISTAMINE FORMULATION TARGETING ALLERGY MARKET

  • GELTEQ LTD - PLANS HUMAN TRIALS FOR FDA APPROVAL

Source text: ID:nGNX2qvvc1

Further company coverage: GELS.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10